3102-57-6
3102-57-6 結(jié)構式
基本信息
CERAMIDE C2
C2 CERAMIDE
C2:0 CERAMIDE
TOC Ceramide
ACETYL CERAMIDE
C14 SPHINGOID BASE
N-ACETYLSPHINGOSINE
C2-D-ERYTHRO-CERAMIDE
N-ACETYL-D-SPHINGOSINE
物理化學性質(zhì)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-101180 | N-乙?；窠?jīng)鞘氨醇 C2 Ceramide | 3102-57-6 | 1 mg | 400元 |
| 2026/06/05 | HY-101180 | N-乙?；窠?jīng)鞘氨醇 C2 Ceramide | 3102-57-6 | 5mg | 1100元 |
| 2026/06/05 | HY-101180 | N-乙?；窠?jīng)鞘氨醇 C2 Ceramide | 3102-57-6 | 10 mM * 1 mLin DMSO | 1210元 |
常見問題列表
Protein phosphatase 1
PP2A
Ceramide-activated protein phosphatase (CAPP)
Apoptosis
Mitochondrial respiratory chain complex III
C2 Ceramide (5 nM-200 μM; 24 hours; primary mouse osteoblasts) treatment (≤500 nM) promots osteoblast viability, whilst concentrations ≥2 μM significantly reduces osteoblast viability in a dose- and time-dependent manner.
C2 Ceramide increases cytoplasmic histone-associated DNA fragments by 5.7- and 11.2-fold at 50 μM and 100 μM C2 Ceramide concentrations respectively in osteoblasts. At these higher concentrations, C2 Ceramide is a potent inducer of apoptosis in osteoblasts.
C2 Ceramide up-regulates mRNA expression of angiogenic genes in human dental pulp cells (HDPCs) and increases the migration and capillary tube formation of endothelial cells, whereas PP1 small interfering RNA shows opposite effects. Human dental pulp cells (HDPCs) increases levels of bone morphogenetic protein 2, phosphorylation of Smad 1/5/8, and mRNA expression of runt-related transcription factor 2 and osterix.
Cell Viability Assay
| Cell Line: | Primary mouse osteoblasts |
| Concentration: | 5 nM-200 μM |
| Incubation Time: | 24 hours |
| Result: | Murine osteoblasts demonstrated a dose-dependent increase in their survival rate when exposed to low concentrations of 5-500 n?M. Increasing concentrations of 20-200μM caused a dose-dependent decrease in mitochondrial succinate dehydrogenase activity and osteoblast survival. |
The PP1 activator C2 Ceramide increases alkaline phosphatase activity, mineralizes nodule formation, and mRNA expression of dentin matrix protein 1 and dentin sialophosphoprotein. In contrast, knockdown by PP1 small interfering RNA inhibits odontoblastic differentiation.